Minimal Residual Disease Testing Market : Size, Trends, and Growth Analysis 2032
The Minimal Residual Disease Testing Market is witnessing robust growth as oncology care increasingly prioritizes early detection, precision medicine, and improved patient outcomes. Valued at USD 1,456 million in 2024, the market is projected to grow at a strong CAGR of 12.5% through 2032. This expansion reflects the growing adoption of highly sensitive diagnostic methods that detect minute...
0 Reacties
0 aandelen
180 Views